Zolpidem Tartrate Tablet, Film Coated, Extended Release
Product Images NDC 72162-2441

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 72162-2441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
This text provides a comparison of the mean plasma concentration-time profiles for Zolpidem Tartrate Extended-Release Tablets (12.5 mg) and Immediate-Release Zolpidem Tartrate (10 mg). The graph shows the plasma concentrations (ng/mL) over time for both formulations, indicating the pharmacokinetic differences between the two types of Zolpidem.*
FDA Label Image

Label (Lbl721622441)

Label (Lbl721622441)
The text describes a medication containing Zolpidem Tartrate in film-coated bi-layer tablets. The usual adult dosage is one tablet at bedtime. It provides information on storage conditions, dosage instructions, and the importance of keeping the medication out of the reach of children. The medication should be dispensed with a Medication Guide. Manufacturing information is also included.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.